Mouse Anti-CDCA4 Recombinant Antibody (CBLC141-LY) (CBMAB-C10784-LY)

Zhang, J. T., Chen, J., Ruan, H. C., Li, F. X., Pang, S., Xu, Y. J., ... & Wu, X. H. (2021). Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4. Cancer Management and Research, 13, 8425.

Li, S., Qin, C., Chen, Y., Wei, D., Tan, Z., & Meng, J. (2021). Implications of cell division cycle associated 4 on the Wilm’s tumor cells viability via AKT/mTOR signaling pathway. Renal failure, 43(1), 1470-1478.

Li, J., Zhang, F., Li, H., Peng, F., Wang, Z., Peng, H., ... & Wei, L. (2020). Circ_0010220-mediated miR-503-5p/CDCA4 axis contributes to osteosarcoma progression tumorigenesis. Gene, 763, 145068.

Pang, S., Xu, Y., Chen, J., Li, G., Huang, J., & Wu, X. (2019). Knockdown of cell division cycle‑associated protein 4 expression inhibits proliferation of triple negative breast cancer MDA‑MB‑231 cells in vitro and in vivo. Oncology Letters, 17(5), 4393-4400.

Xu, Y., Wu, X., Li, F., Huang, D., & Zhu, W. (2018). CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF‑7/ADM human breast cancer cell line. Molecular Medicine Reports, 17(1), 1507-1512.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols